| Tag | Content |
|---|
EnhancerAtlas ID | HS165-06855 |
Organism | Homo sapiens |
Tissue/cell | Ramos |
Coordinate | chr19:1027630-1029450 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF5 | MA0599.1 | chr19:1028850-1028860 | GGGGCGGGGC | - | 6.02 | | RREB1 | MA0073.1 | chr19:1028251-1028271 | GGGGTGGGGTGGGGTGGGGG | - | 6.74 | | RREB1 | MA0073.1 | chr19:1028250-1028270 | CGGGGTGGGGTGGGGTGGGG | - | 7.29 | | SP2 | MA0516.2 | chr19:1027637-1027654 | TGGGGGGCGGGGGTTGT | - | 6.57 | | ZNF263 | MA0528.1 | chr19:1028700-1028721 | GGGGGCGGGGGTGGGGGAGGA | + | 6.44 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_03077 | chr19:1027724-1029076 | Bladder | | SE_45457 | chr19:1026001-1029225 | NHLF | | SE_49748 | chr19:1027748-1028719 | Right_Ventricle | | SE_49748 | chr19:1028730-1029057 | Right_Ventricle | | SE_69051 | chr19:1025636-1029189 | H9 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GGGAAAGTGG GGGGCGGGGG TTGTGATGCG AGACCCACGG ACAGGACCGG GACCTGACCC 60
TCCAGGACCT TCCAGCTGGA GGGGGGTGTC GTCCCCGCCC ACCCCCTCCC CCGACGCCCA 120
CTGGGCACCT GGGAAGGTGT CCTTACAGCT GACTTCTGCA GGGGAAACTG CCTCTGCACG 180
CTCTGAGGGC ACCGGCCCTG CCAGCCCCAA CAGCCACCTG CCCGGCGGCA CTCCAGGGCC 240
GGCAGACTGG AGGGAGAATT CCTGCTTCCC CGCTGTGAGC CCCTGCAAGC CTTCAGACCA 300
GCTCTTGGCC AAAAAGGGAG GCTGAGGCTT GGGGTGGTCA AGGCCTGAGC CAGGGTCCCC 360
AGCCCGGGGC TCACGACTCC TCCTTCAAGG GGCCATCTGC ACCCTGCATT CATAGAGCCC 420
CCCGTGCAGT GGGGTGGGCA CCCTGCCGCA CCCTGCATAC AGCCGGCTAA GGGCACCGGT 480
GTCCACAGGG ACCCAGAGAC GTCGTTCCAG CTGCCCAGGG CCACACAGCC CACAAGTGAC 540
AGGGCCAAGA CCGGAACCCA GTACCTGCTG GGCCTGCGGA AGTGGGAGCG GGCACAGGAG 600
GGTGGGGCGG CTTCCGGAGA CGGGGTGGGG TGGGGTGGGG GCAGGTTGAT ACCTGCCCTG 660
GCGGGGGTGA GGACAGAGGC TGGAAGAGCC GCTTAGCAGG CTCCCCGCGC AACCCTCAGT 720
CTGTCCGTTT GGAGGGTGGG CGAGGCGTCG GCCAGCTTGC CAGGGTCACG GAAGGGTCGC 780
CTCCCAATTA GAAACCAGCT TCCCCCTGGC TTCCCGCTCA CACCCGCTTT ACCGGCTGCT 840
TGAAACAGCC AGAGACCCGC CCCCCGCCCC GCTTCCCCGT GGCTCAGTTG ACTCCCGGCT 900
GGACGGCACG GAGGCAGCTC GGATCCACAG TGTCTGCGGC CTTGCATCCC GGCTTGGGGG 960
TCCGGACCCG CTGGGAACAG CTGGTTCAGA TTTAGCCGGG GAGGCAGCGC GCATTCCTGG 1020
CAGTTTGTGG TGAACAGGAA TGTGCTGGAA GGCCGGCGGC CGGGCAGCGG GGGGGCGGGG 1080
GTGGGGGAGG ACGGCAGCGG CTGGGGGTGG GGCCAGGGGA CCTGGGCCCC TGAGCCGGCA 1140
GAGACGCGGC GCAGCTGGGC AAGGCAGGGC TGTGTACCCA GCAGCCACCG TTCTCATTCC 1200
TCGGGATCAA AGTTGCCGGC GGGGCGGGGC TGCCCCCGGG CGTGGAAAGC CAAGCTGGGT 1260
GGGCTGTGAG CTGGTACTGG GGGGCCTCCC CGCCTTTGCC TCCTCTGGGC TACGAGCTGT 1320
TTCCAGGCAG GTGCCAGGTC AGGGGACCCT AACCCAAATA ATCCCAGGCA GGTCCAGGTC 1380
AGGGGACCCT ATCCCAAATA ATCCCAGGCA GGTCCAGCTC AGGGGACCCT AACCCAAATC 1440
ATCCCAGGCA GGTCCAGCTC AGGGGACCCT AACCCAAATC ATCCCAGGCA GGTCCAGCTC 1500
AGGGGACCCT AACCCAAATC ATCCCAGGCA GGTCCAGCTC AGGGGACCCT ACCCAAATCA 1560
TTCCAGGCAG ATCTAGCTCA GGGGACCCTA ACCCAAATCA TCCCAGGCAG GTCCAGCTCA 1620
GGGGACCCTA ACCCAAATCA TCCCAGGCAG GTCCAGCTCA GGGGACCCTA ACCCAAATCA 1680
TCCCAGGCAG GTCCAGGTCA GGGGACCCTA CCCAAATCAT CCCAGGCAGG TCTAGCTCAG 1740
GGGACCCTAA CCCAAATCAT CCCAGGCAGG TCCAGCTCAG GGGACCCTAA CCCAAATCAT 1800
CCCAGGCAGG TCCAGCTCAG 1820
|
